During the past decade, AMCR Institute conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 36 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 13 clinical trials were completed. i.e. 86.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AMCR Institute" #1 sponsor was "Ascensia Diabetes Care" with 17 trials, followed by "Medtronic Diabetes" with 15 trials sponsored, "DexCom, Inc." with 6 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored and "Becton, Dickinson and Company" with 6 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AMCR Institute" #1 collaborator was "AMCR Institute" with 3 trials as a collaborator, "Integrated Medical Development" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Diablo Clinical Research" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "AMCR Institute" are "Diabetes" (20 trials), "Diabetes Mellitus" (15 trials), "Diabetes Mellitus, Type 1" (12 trials), "Type 1 Diabetes" (8 trials) and "Type 1 Diabetes Mellitus" (8 trials). Many other conditions were trialed in "AMCR Institute" in a lesser frequency.

Most popular intervention types in "AMCR Institute" are "Device" (49 trials), "Drug" (22 trials), "Combination Product" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Continuous Glucose Monitoring System" (4 trials), "Continuous Glucose Monitoring" (3 trials), "Insulin Degludec" (3 trials) and "Insulin Glargine" (2 trials). Other intervention names were less common.

The vast majority of trials in "AMCR Institute" are 76 trials for "All" genders.

Currently, there are NaN active trials in "AMCR Institute". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in AMCR Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in AMCR Institute, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 43 trials that are defined as “Not Applicable".